Trial Profile
Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension
Status:
Recruiting
Phase of Trial:
Phase 0
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Ritonavir (Primary) ; Saquinavir (Primary)
- Indications Pulmonary arterial hypertension
- Focus Pharmacodynamics
- 28 Jan 2014 New trial record